Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer

NCT06342401 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06342401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2023
Completion date
June 18, 2028
Enrollment
400 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer, colorectal cancer stage i, colorectal cancer stage ii, colorectal cancer stage iii, colorectal cancer stage iv, colorectal neoplasms, colorectal neoplasms malignant